paxilline has been researched along with Macular Degeneration in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishibashi, T; Kimura, K; Kurakazu, T; Liu, Y; Morishige, N; Noda, T; Orita, T; Sonoda, KH; Takeda, A; Tokuda, K; Yanai, R; Yang, Y | 1 |
1 other study(ies) available for paxilline and Macular Degeneration
| Article | Year |
|---|---|
Attenuation of EMT in RPE cells and subretinal fibrosis by an RAR-γ agonist.
Topics: Actins; Animals; Cell Line; Collagen; Dipeptides; Epithelial-Mesenchymal Transition; Extracellular Signal-Regulated MAP Kinases; Fibronectins; Fibrosis; Glial Fibrillary Acidic Protein; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Macular Degeneration; Matrix Metalloproteinases; Mice; p38 Mitogen-Activated Protein Kinases; Paxillin; Proto-Oncogene Proteins c-akt; Pyrazoles; Receptors, Retinoic Acid; Retina; Retinal Pigment Epithelium; Retinoic Acid Receptor gamma; Smad2 Protein; Transforming Growth Factor beta2 | 2015 |